John Burnett

Search results

• 2017

  Elevated lipoprotein (a) and familial hypercholesterolaemia phenotypes in patients admitted to a coronary care unit with coronary artery disease

  Ellis, K., Pang, J., Bell, D., Burnett, J., Schultz, C., Hillis, G. & Watts, G., Aug 2017, In: Atherosclerosis. 263, p. E99-E99 1 p., SAG195.

  Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

• Isolated Elevation of Lipoprotein(a) is Uncommon Among Patients Admitted to Coronary Care

  Ellis, K. L., Pang, J., Bell, D. A., Burnett, J. R., Schultz, C., Hillis, G. S. & Watts, G. F., 2017, In: Heart, Lung and Circulation. 26, Supp. 2, p. S84 1 p.

  Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

• Lipoprotein (a) Level is Associated with Angiographic Disease Complexity (SYNTAX score) in Patients with Premature Coronary Artery Disease

  Chieng, D., Pang, J., Ellis, K. L., Bell, D. A., Burnett, J. R., Hillis, G. S. & Schultz, C., 2017, In: Heart, Lung and Circulation. 26, Supp. 2, p. S119

  Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

• Predictors of subclinical coronary artery disease in asymptomatic patients with familial hypercholesterolaemia

  Pang, J., Abraham, A., Bates, T. R., Bell, D. A., Hooper, A. J., Burnett, J. R. & Watts, G. F., Aug 2017, In: Atherosclerosis. 263, p. E228-E228 1 p.

  Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

• Systematic Screening for Familial Hypercholesterolaemia and Elevated Lp (a) in Families

  Ellis, K. L., Pang, J., Bell, D. A., Hooper, A. J., Burnett, J. R. & Watts, G. F., 2017, In: Heart, Lung and Circulation. 26, Supp. 2, p. S121-S122

  Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review
• 2016

  The prevalence of familial hyperlipidaemia and hyper-lipoprotein (a) in mutation-negative familial hypercholesterolaemia and associations with cardiovascular events

  Ellis, K. L., Pang, J., Chan, C. F., Hooper, A. J., Bell, D. A., Burnett, J. R. & Watts, G. F., 2016, In: Atherosclerosis. 252, e202.

  Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review
• 2004

  A novel nontruncating APOB gene mutation, L343V, causes familial hypobetalipoproteinemia

  Whitfield, A., Crawford, G., Barrett, P., Robertson, K., Hegele, R., Tran, K., Yao, Z., Van Bockxmeer, F. & Burnett, J., 2004, In: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 24, 5, p. E55-E55

  Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review
• 2003

  A novel truncating APOB gene mutation, apoB-40.3, causing familial hypobetalipoproteinaemia

  Whitfield, A., Robertson, K., Barrett, P., Van Bockxmeer, F. & Burnett, J., 2003, In: Clinical and Experimental Pharmacology and Physiology. 30, p. A25-A25

  Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

  13 Citations (Scopus)
• 2002

  Combination of a novel inhibitor of the apical sodium-bile acid cotransporter, SC-435, and atorvastatin reduces LDL-cholesterol through decreased secretion and enhanced clearance of LDL ApoB

  Telford, D., Burnett, J., Barrett, P., Keller, B. & Huff, M., 2002, In: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 22, p. A42-A42

  Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

  67 Citations (Scopus)